Portage Biotech Inc (PRTG)
0.2606
0.00 (0.00%)
USD |
NASDAQ |
May 20, 10:37
Portage Biotech Total Liabilities (Quarterly): 17.70M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 17.70M |
September 30, 2023 | 25.40M |
June 30, 2023 | 25.72M |
March 31, 2023 | 23.73M |
December 31, 2022 | 42.38M |
September 30, 2022 | 38.72M |
June 30, 2022 | 27.86M |
March 31, 2022 | 29.23M |
December 31, 2021 | 24.24M |
September 30, 2021 | 24.86M |
June 30, 2021 | 26.68M |
March 31, 2021 | 27.26M |
December 31, 2020 | 22.93M |
September 30, 2020 | 26.49M |
June 30, 2020 | 27.64M |
March 31, 2020 | 27.53M |
December 31, 2019 | 25.59M |
September 30, 2019 | 25.22M |
June 30, 2019 | 25.46M |
March 31, 2019 | 25.16M |
December 31, 2018 | 0.397M |
September 30, 2018 | 0.293M |
June 30, 2018 | 0.357M |
March 31, 2018 | 0.384M |
December 31, 2017 | 2.375M |
Date | Value |
---|---|
September 30, 2017 | 0.427M |
June 30, 2017 | 0.3738M |
March 31, 2017 | 0.31M |
December 31, 2016 | 0.1312M |
September 30, 2016 | 0.0768M |
June 30, 2016 | 1.048M |
March 31, 2016 | 0.2997M |
December 31, 2015 | 0.0813M |
September 30, 2015 | 0.1759M |
June 30, 2015 | 0.628M |
March 31, 2015 | 0.6206M |
December 31, 2014 | 1.016M |
September 30, 2014 | 0.5829M |
June 30, 2014 | 0.4964M |
March 31, 2014 | 0.192M |
December 31, 2013 | 0.0944M |
September 30, 2013 | 0.0997M |
June 30, 2013 | 0.1701M |
March 31, 2013 | 0.4469M |
December 31, 2012 | 0.1251M |
September 30, 2012 | 0.3278M |
June 30, 2012 | 1.298M |
March 31, 2012 | 2.662M |
December 31, 2011 | 1.014M |
September 30, 2011 | 0.7154M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.70M
Minimum
Dec 2023
42.38M
Maximum
Dec 2022
27.09M
Average
25.72M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
Intensity Therapeutics Inc | 2.686M |
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 49.04M |
Shareholders Equity (Quarterly) | 32.00M |